J Dig Cancer Res.
2020 Dec;8(2):97-101.
The Metformin Use and Gastric Cancer Risk
- Affiliations
-
- 1Center for Gastric Cancer, National Cancer Center, Goyang, Korea
Abstract
- Metformin is a widely used first-line anti-diabetic drug worldwide. Epidemiologic studies using the large population-based cohort database have shown the association between metformin uses and reduced risk of various type cancers including gastric cancer. In the gastric cancer prevention, metformin use was associated with the significant reduction of gastric cancer risk, especially for long-term metformin users. However, there is no well-designed randomized controlled clinical trial investigating the effect of metformin as a chemopreventive drug for gastric cancer. Therefore, further well-designed clinical trials will be needed to implement metformin for chemoprevention of gastric cancer.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Chemoprevention of Gastric Cancer: Metformin
- Association between Metformin Therapy and Breast Cancer Incidence and Mortality: Evidence from a Meta-Analysis
- The Relationship between Metformin and Cancer in Patients with Type 2 Diabetes
- Effect of Immortal Time Bias Controlled Metformin for Cancer Development in Diabetic Patients
- Effects of Metformin on Breast Cancer Risk and Mortality in Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis
